
RobotLAB Expands “AI, Robotics & the Future of Work” Lineup
DALLAS--(BUSINESS WIRE)--Jul 6, 2023--
2023-07-07 05:59

Marketmind: Markets buckle under US rates, China blues
By Jamie McGeever A look at the day ahead in Asian markets from Jamie McGeever, financial markets columnist.
2023-07-07 05:58

Levi Lowers Full-Year Guidance on US Wholesale Weakness
Levi Strauss & Co. lowered its guidance for the full-year, citing weakness in its US wholesale business and
2023-07-07 05:56

Taylor Swift agreed to $100 million deal with FTX before it went bankrupt, but FTX pulled out
Taylor Swift signed onto a lucrative touring partnership with FTX before its collapse, but FTX pulled out of the arrangement, according to a person familiar with the discussions.
2023-07-07 05:53

Cierto Tequila Awarded Five Double Gold Medals at the 2023 Singapore World Spirits Competition
LOS ANGELES--(BUSINESS WIRE)--Jul 6, 2023--
2023-07-07 05:50

Birkenstock Owner Considers IPO at $6 Billion-Plus Value
L Catterton, the private equity firm backed by luxury French fashion house LVMH, is considering strategic options for
2023-07-07 05:46

BOJ Deputy Governor Uchida: Will maintain yield control to sustain easy policy
By Leika Kihara TOKYO Bank of Japan (BOJ) Deputy Governor Shinichi Uchida said the central bank will maintain
2023-07-07 05:45

Railroad industry sues to block limit on crew sizes that Ohio imposed after E. Palestine derailment
The railroad industry has sued to block a new minimum crew-size requirement that Ohio imposed after a fiery train derailment in East Palestine in February
2023-07-07 05:25

John Kerry to Visit China in Bid for Progress in Climate Crisis Talks
US Climate Envoy John Kerry is heading to China for talks on global warming as tensions simmer between
2023-07-07 05:22

AbbVie trims full-year profit forecast on higher R&D expenses
(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development
2023-07-07 05:20

Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:16

L Catterton considering IPO for Birkenstock at $6 billion- Bloomberg News
L Catterton, a private equity firm backed by LVMH, is considering strategic options for Birkenstock including an initial
2023-07-07 05:15
You Might Like...

Sri Lankan economy to see growth next year after 3.8% contraction, says World Bank

How the Supreme Court student loan decision affects you

Teamsters chief says still open to deal with UPS

Exclusive-Kenya plans $500 million Eurobond buyback with new loans - cenbank governor

Pumpkin Spice Lovers Will ‘Fall’ Hardest for KRISPY KREME’S® New Pumpkin Spice Collection Beginning Aug. 7

US furniture retailer RH shares tumble as slowing sales prompt dour revenue forecast

What day and time will 'Shark Tank' Season 15 air? Release date, time and how to watch

Can High Schools Do More to Prevent Bullying?